Longitudinal Evaluation of Humoral Immunity and Bacterial and Clinical Parameters Reveals That Antigen-Specific Antibodies Suppress Inflammatory Responses in Active Tuberculosis Patients

A novel tuberculosis vaccine to replace BCG has long been desired. However, recent vaccine trials focused on cell-mediated immunity have failed to produce promising results. It is worth noting that most commercially available successful vaccines rely on humoral immunity. To establish a basic underst...

Descripción completa

Detalles Bibliográficos
Autores principales: Niki, Mamiko, Yoshiyama, Takashi, Miyamoto, Yuji, Okumura, Masao, Niki, Makoto, Oinuma, Ken-ichi, Kaneko, Yukihiro, Matsumoto, Sohkichi, Sasaki, Yuka, Ogata, Hideo, Goto, Hajime, Kudoh, Shoji, Hoshino, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057312/
https://www.ncbi.nlm.nih.gov/pubmed/30069487
http://dx.doi.org/10.1155/2018/4928757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057312/
https://www.ncbi.nlm.nih.gov/pubmed/30069487
http://dx.doi.org/10.1155/2018/4928757

Ejemplares similares